. 2016 Oct 20;11(10):e0164030. doi: 10.1371/journal.pone.0164030

Table 2. Immunologic, virologic and adherence patterns by baseline CD4+ cell count, previously ARV-naïve patients (N = 70,002).

	Baseline CD4+ Cell Count, cells/mm³					p-value
Outcome/pattern evaluated	≤100	101–200	201–350	351–500	>500	p-value
CD4+ cell count change by month 6, cells/mm³ (IQR)	120	140	140			<0.0001
CD4+ cell count change by month 6, cells/mm³ (IQR)	(63–196)	(66–234)	(47–251)			<0.0001
% with viral suppression^* by month 6	65.4	70.7	73.3	71.4	64.4	<0.001
% with viral suppression^* by month 12	72.3	77.0	79.3	78.4	73.1	<0.001
% with average adherence ≥95% at month 6	63.1	62.9	64.2	56.5	52.5	<0.001
% with average adherence <50% at month 6	6.4	6.5	6.3	11.7	14.3	<0.001

*Viral suppression defined as VL≤400 cp/mL